Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly total equity is $116.62M with QoQ Growth of (2.78%). Total equity, also called shareholders' equity, is assets minus liabilities. The book value in P/B is the part attributable to common shareholders: total equity minus preferred stock.
Reported quarterly total equity; no daily interpolation. Q4 FY2026 (2026-06-30): $116.62M.
FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock) Quote observation: 2026-10-06T12:55:24.675Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Period | Total Equity | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q4 FY2026Period end 2026-06-30 | $116.62M | (2.78%) | +12.98% |
| Q3 FY2026Period end 2026-03-31 | $119.95M | +2.01% | +23.15% |
| Q2 FY2026Period end 2025-12-31 | $117.58M | +8.75% | +23.06% |
| Q1 FY2026Period end 2025-09-30 | $108.13M | +4.75% | +22.84% |
| Q4 FY2025Period end 2025-06-30 | $103.22M | +5.98% | +17.79% |
| Q3 FY2025Period end 2025-03-31 | $97.40M | +1.94% | +14.42% |
| Q2 FY2025Period end 2024-12-31 | $95.55M | +8.55% | +7.96% |
| Q1 FY2025Period end 2024-09-30 | $88.03M | +0.45% | +11.80% |
| Q4 FY2024Period end 2024-06-30 | $87.63M | +2.94% | +10.18% |
| Q3 FY2024Period end 2024-03-31 | $85.13M | (3.82%) | +1.39% |
| Q2 FY2024Period end 2023-12-31 | $88.50M | +12.41% | (4.32%) |
| Q1 FY2024Period end 2023-09-30 | $78.73M | (1.01%) | (22.37%) |
| Q4 FY2023Period end 2023-06-30 | $79.53M | (5.27%) | (26.98%) |
| Q3 FY2023Period end 2023-03-31 | $83.96M | (9.23%) | (27.66%) |
| Q2 FY2023Period end 2022-12-31 | $92.50M | (8.80%) | N/A |
| Q1 FY2023Period end 2022-09-30 | $101.42M | (6.89%) | N/A |
| Q4 FY2022Period end 2022-06-30 | $108.93M | (6.15%) | N/A |
| Q3 FY2022Period end 2022-03-31 | $116.06M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
